Quintiles has opened its expanded research facility in London, UK, increasing Phase I capacity and extending its capabilities in translational medicine. The expansion brings the total number of Phase I beds in London to 105 and globally to 385. Additionally, the company has plans to open a Phase I unit in Hyderabad, India, in late 2010. This facility initially will have 50 beds, with capacity for expansion to 100. “Declining productivity in R&D means that the biopharmaceutical industry is...